Department of Mining, Metallurgy and Materials Engineering, Université Laval and Centre de Recherche du Centre Hospitalier Universitaire de Québec (CR-CHUQ), Axe Médecine Régénératrice , Québec, Quebec G1L 3L5, Canada.
Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) , 1011 Lausanne, Switzerland.
Langmuir. 2017 Oct 10;33(40):10531-10542. doi: 10.1021/acs.langmuir.7b01792. Epub 2017 Sep 26.
The development of molecular and cellular magnetic resonance imaging (MRI) procedures has always represented a challenge because of the fact that conventional MRI contrast agents are not directly detected in vivo; in proton MRI (e.g., with the nucleus H), their local concentration is measured through the effect they exert on the signal of hydrogen protons present in their immediate vicinity. Because the contrast effects generated by conventional MRI probes superpose to and can often impede the anatomical information contained in H MRI images, new probes based on a nucleus other than H, are being developed. In this study, we report on the development of fluorinated mesoporous silica nanoparticles (MSNs), which could represent an interesting dual probe that allows two MRI modes: H for high-resolution anatomical information and F for the detection of MSNs used as drug delivery agents. MSNs were synthesized and covalently functionalized either with fluorosilane (FMSNs) or polyfluorosiloxane (polyFMSNs) to enable their detection in F MRI. Then, gadolinium chelates were grafted on the particles to enhance their detectability in H MRI. The physicochemical, textural, and relaxometric properties (H and F relaxation times) of the nanoparticles were measured and compared. The F relaxation properties were found to be dependent on the concentration of fluorine; they were also highly sensitive to the presence of gadolinium. The shortest relaxation times were obtained with polyFMSNs. At clinical magnetic field strengths, high H relaxivities and low relaxometric ratios (r/r = 1.45; 2.2 for nanoparticles entrapped in hydrogel) were found for both nanoparticle systems. Finally, the visibility of both systems was confirmed in H, and the detectability of polyFMSNs was confirmed in F MRI. This physicochemical and relaxometric study opens the door to the applications of fluorinated silica nanoparticles as theranostic materials allowing dual MRI (H and F).
分子和细胞磁共振成像(MRI)技术的发展一直是一个挑战,因为常规的 MRI 对比剂不能在体内直接检测到;在质子 MRI 中(例如,使用核 H),通过它们对其附近氢质子信号的影响来测量其局部浓度。由于常规 MRI 探针产生的对比效应会叠加并经常阻碍 H MRI 图像中包含的解剖信息,因此正在开发基于 H 以外的核的新探针。在这项研究中,我们报告了氟化介孔硅纳米粒子(MSNs)的开发,它可能代表一种有趣的双探针,允许两种 MRI 模式:H 用于高分辨率解剖信息,F 用于检测用作药物递送剂的 MSNs。MSNs 被合成并通过氟硅烷(FMSNs)或聚氟硅氧烷(polyFMSNs)共价功能化,以使其能够在 F MRI 中被检测到。然后,将钆螯合物接枝到颗粒上以增强其在 H MRI 中的检测能力。测量和比较了纳米粒子的物理化学、结构和弛豫特性(H 和 F 弛豫时间)。发现 F 弛豫特性取决于氟的浓度;它们也对钆的存在高度敏感。polyFMSNs 获得了最短的弛豫时间。在临床磁场强度下,对于两种纳米粒子系统,均获得了高 H 弛豫率和低弛豫比(r/r=1.45;2.2 为水凝胶中包封的纳米粒子)。最后,在 H 中证实了两种系统的可见性,并在 F MRI 中证实了 polyFMSNs 的可检测性。这项物理化学和弛豫研究为将氟化硅纳米粒子作为允许双重 MRI(H 和 F)的治疗诊断材料的应用开辟了道路。